Product Detail
Ombitasvir-d16
Stable Isotopes
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
--
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
Ombitasvir-d16 Product Information
Ombitasvir-d16 is listed under Stable Isotopes. It is associated with and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-96690.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Ombitasvir-d16
CAS No.
-
CAT No.
CS-T-96690
Molecular Formula
C50H51D16N7O8
Molecular Weight
910.21
Category
Storage Condition
Refer MSDS for complete information.
IUPAC Name
Ombitasvir-d16
Hazard Compound
Refer MSDS for complete information.
Description
Overview
"Ombitasvir-d16 is labelled Ombitasvir (O633200), which is a pharmaceutical drug that is used in the treatment of hepatitis C virus in patients with HCV genotype 1 infection. Ombitasvir inhibits an important viral phosphoprotein, NS5A, which is involved in viral replication, assembly, and secretion."
Synonyms
"ABT 267 - d16; 2,2'-[[(2S,5S)-1-[4-(1,1-Dimethylethyl)phenyl]-2,5-pyrrolidinediyl]di-4,1-phenylene]bis[N-(methoxycarbonyl)-L-valyl-L-prolinamide]-d16"
Application Notes
"Ombitasvir-d16 is labelled Ombitasvir (O633200), which is a pharmaceutical drug that is used in the treatment of hepatitis C virus in patients with HCV genotype 1 infection. Ombitasvir inhibits an important viral phosphoprotein, NS5A, which is involved in viral replication, assembly, and secretion."
References
"Feld, J.J., et al.: New Eng. J. Med., 370, 1594 (2014); Lawitz, E., et al.: J. Hepatol., 57, 24 (2012); Afdhal, N., et al.: New England J. Med., 370, 1889 (2014)"